Literature DB >> 26254342

CX3CL1-CX3CR1 Interaction Increases the Population of Ly6C(-)CX3CR1(hi) Macrophages Contributing to Unilateral Ureteral Obstruction-Induced Fibrosis.

Xiaogang Peng1, Jing Zhang2, Zhicheng Xiao2, Yanjun Dong2, Jie Du3.   

Abstract

Chemokines modulate inflammatory responses that are prerequisites for kidney injury. The specific role of monocyte-associated CX3CR1 and its cognate ligand CX3CL1 in unilateral ureteral obstruction (UUO)-induced kidney injury remains unclear. In this study, we found that UUO caused a CCR2-dependent increase in numbers of Ly6C(hi) monocytes both in the blood and kidneys and of Ly6C(-)CX3CR1(+) macrophages in the obstructed kidneys of mice. Using CX3CR1(gfp/+) knockin mice, we observed a rapid conversion of infiltrating proinflammatory Ly6C(+)CX3CR1(1o) monocytes/macrophages to anti-inflammatory Ly6C(-)CX3CR1(hi) macrophages. CX3CR1 deficiency affected neither monocyte trafficking nor macrophage differentiation in vivo upon renal obstruction, but CX3CR1 expression in monocytes and macrophages was required for increases in fibrosis in the obstructed kidneys. Mechanistically, CX3CL1-CX3CR1 interaction increases Ly6C(-)CX3CR1(hi) macrophage survival within the obstructed kidneys. Therefore, CX3CL1 and CX3CR1 may represent attractive therapeutic targets in obstructive nephropathy.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26254342     DOI: 10.4049/jimmunol.1403209

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  CCR2 contributes to the recruitment of monocytes and leads to kidney inflammation and fibrosis development.

Authors:  Tarcio Teodoro Braga; Matheus Correa-Costa; Reinaldo Correia Silva; Mario Costa Cruz; Meire Ioshie Hiyane; Joao Santana da Silva; Katia Regina Perez; Iolanda Midea Cuccovia; Niels Olsen Saraiva Camara
Journal:  Inflammopharmacology       Date:  2017-02-06       Impact factor: 4.473

2.  The homozygous CX3CR1-M280 mutation impairs human monocyte survival.

Authors:  Amanda L Collar; Muthulekha Swamydas; Morgan O'Hayre; Md Sanaullah Sajib; Kevin W Hoffman; Satya P Singh; Ahmad Mourad; Melissa D Johnson; Elise Mn Ferre; Joshua M Farber; Jean K Lim; Constantinos M Mikelis; J Silvio Gutkind; Michail S Lionakis
Journal:  JCI Insight       Date:  2018-02-08

Review 3.  Progression of chronic kidney disease: too much cellular talk causes damage.

Authors:  Leslie Gewin; Roy Zent; Ambra Pozzi
Journal:  Kidney Int       Date:  2016-10-20       Impact factor: 10.612

Review 4.  Gut Mycobiota in Immunity and Inflammatory Disease.

Authors:  Xin V Li; Irina Leonardi; Iliyan D Iliev
Journal:  Immunity       Date:  2019-06-18       Impact factor: 31.745

5.  Ly6chi Infiltrating Macrophages Promote Cyst Progression in Injured Conditional Ift88 Mice.

Authors:  Ernald Jules G Aloria; Cheng J Song; Zhang Li; Mandy J Croyle; Michal Mrug; Kurt A Zimmerman; Bradley K Yoder
Journal:  Kidney360       Date:  2021-06-24

6.  F4/80hi Resident Macrophages Contribute to Cisplatin-Induced Renal Fibrosis.

Authors:  Sophia M Sears; Alexis A Vega; Zimple Kurlawala; Gabrielle B Oropilla; Austin Krueger; Parag P Shah; Mark A Doll; Robert Miller; Levi J Beverly; Leah J Siskind
Journal:  Kidney360       Date:  2022-02-10

7.  Renal tubular PAR2 promotes interstitial fibrosis by increasing inflammatory responses and EMT process.

Authors:  Sugyeong Ha; Ki Wung Chung; Jaewon Lee; Hae Young Chung; Hyung Ryong Moon
Journal:  Arch Pharm Res       Date:  2022-03-25       Impact factor: 4.946

8.  Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.

Authors:  Divya Bhatia; Kuei-Pin Chung; Kiichi Nakahira; Edwin Patino; Michelle C Rice; Lisa K Torres; Thangamani Muthukumar; Augustine Mk Choi; Oleh M Akchurin; Mary E Choi
Journal:  JCI Insight       Date:  2019-12-05

Review 9.  Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis.

Authors:  Yiping Liu; Yan-Yan Su; Qian Yang; Tianbiao Zhou
Journal:  Stem Cell Res Ther       Date:  2021-06-10       Impact factor: 6.832

10.  Deletion of Myeloid Interferon Regulatory Factor 4 (Irf4) in Mouse Model Protects against Kidney Fibrosis after Ischemic Injury by Decreased Macrophage Recruitment and Activation.

Authors:  Kensuke Sasaki; Andrew S Terker; Yu Pan; Zhilian Li; Shirong Cao; Yinqiu Wang; Aolei Niu; Suwan Wang; Xiaofeng Fan; Ming-Zhi Zhang; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2021-02-22       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.